Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2014 (2014), Article ID 307317, 6 pages
http://dx.doi.org/10.1155/2014/307317
Clinical Study

Intensive Care Unit Admission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Is It Necessary?

1Department of Gastroenterology, National Cancer Institute, San Fernando No. 22, Colonia Seccion XVI, 14050 México City, DF, Mexico
2Department of Medical Oncology, National Cancer Institute, San Fernando No. 22, Colonia Seccion XVI, 14080 México City, DF, Mexico
3Department of Embryology at the National Autonomous University of Mexico (UNAM), Insurgentes Sur s/n, Ciudad Universitaria, Colonia Copilco Universidad, 04360 México City, DF, Mexico
4Department of Critical Care Medicine, National Cancer Institute, San Fernando No. 22, Colonia Seccion XVI, 14080 México City, DF, Mexico

Received 20 November 2013; Revised 29 January 2014; Accepted 3 March 2014; Published 22 April 2014

Academic Editor: P. Neven

Copyright © 2014 Horacio N. López-Basave et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Stephens, R. Alderman, D. Chang et al., “Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique,” Annals of Surgical Oncology, vol. 6, no. 8, pp. 790–796, 1999. View at Google Scholar · View at Scopus
  2. N. J. Gusani, S. W. Cho, C. Colovos et al., “Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center,” Annals of Surgical Oncology, vol. 15, no. 3, pp. 754–763, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Kusamura, R. Younan, D. Baratti et al., “Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique,” Cancer, vol. 106, no. 5, pp. 1144–1153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Bijelic, T. D. Yan, and P. H. Sugarbaker, “Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer,” Annals of Surgical Oncology, vol. 14, no. 8, pp. 2281–2288, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Baratti, S. Kusamura, A. D. Cabras, P. Dileo, B. Laterza, and M. Deraco, “Diffuse malignant peritoneal mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC),” Annals of Surgical Oncology, vol. 16, no. 2, pp. 463–472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Jacquet, A. D. Stephens, A. M. Averbach et al., “Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy,” Cancer, vol. 77, no. 12, pp. 2622–2629, 1996. View at Google Scholar · View at Scopus
  7. J. H. Stewart IV, P. Shen, G. B. Russell et al., “Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy,” Annals of Surgical Oncology, vol. 13, no. 5, pp. 624–634, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Younan, S. Kusamura, D. Baratti, A.-S. Cloutier, and M. Deraco, “Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy,” Journal of Surgical Oncology, vol. 98, no. 4, pp. 253–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. E. de Bree, A. J. Witkamp, and F. A. N. Zoetmulder, “Intraperitoneal chemotherapy for colorectal cancer,” Journal of Surgical Oncology, vol. 79, no. 1, pp. 46–61, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Pilati, C. R. Rossi, S. Mocellin et al., “Multimodal treatment of peritoneal carcinomatosis and sarcomatosis,” European Journal of Surgical Oncology, vol. 27, no. 2, pp. 125–134, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. L. G. Bayón, P. H. Sugarbaker, S. G. Moreno, V. L. Vazquez, S. Alves, and B. J. Moran, “Initiation of a program in peritoneal surface malignancy,” Surgical Oncology Clinics of North America, vol. 12, no. 3, pp. 741–753, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Jayne, “Molecular biology of peritoneal carcinomatosis,” Cancer Treatment and Research, vol. 134, pp. 21–33, 2007. View at Google Scholar · View at Scopus
  13. P. Jacquet, A. D. Stephens, A. M. Averbach et al., “Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy,” Cancer, vol. 77, no. 12, pp. 2622–2629, 1996. View at Google Scholar · View at Scopus
  14. V. J. Verwaal, H. van Tinteren, S. V. Ruth, and F. A. Zoetmulder, “Toxicity of citoreductive surgery and hyperthermic intra-peritoneal chemotherapy,” Journal of Surgical Oncology, vol. 85, no. 2, pp. 61–67, 2004. View at Publisher · View at Google Scholar
  15. D. Elias, S. Antoun, B. Raynard et al., “Treatment of peritoneal carcinomatosis with complete cytoreductive surgery and intraperitoneal chemohyperthermia (IPCH). A phase I-II study in order to define the best procedure,” Chirurgie, vol. 124, no. 4, pp. 380–389, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. P. H. Sugarbaker, “It's what the surgeon doesn't see that kills the patient,” Journal of Nippon Medical School, vol. 67, no. 1, pp. 5–8, 2000. View at Google Scholar · View at Scopus
  17. S. Rufián, F. C. Muñoz-Casares, J. Briceño et al., “Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer,” Journal of Surgical Oncology, vol. 94, no. 4, pp. 316–324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C. R. Rossi, M. Deraco, M. de Simone et al., “Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients,” Cancer, vol. 100, no. 9, pp. 1943–1950, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. P. H. Sugarbaker, R. Alderman, G. Edwards et al., “Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy,” Annals of Surgical Oncology, vol. 13, no. 5, pp. 635–644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. R. M. Smeenk, A. Bex, V. J. Verwaal, S. Horenblas, and F. A. N. Zoetmulder, “Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications,” Journal of Surgical Oncology, vol. 93, no. 1, pp. 20–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. E. Bristow, R. S. Tomacruz, D. K. Armstrong, E. L. Trimble, and F. J. Montz, “Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis,” Journal of Clinical Oncology, vol. 20, no. 5, pp. 1248–1259, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. F. A. N. Zoetmulder and P. H. Sugarbaker, “Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin,” European Journal of Cancer A, vol. 32, no. 10, pp. 1727–1733, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Sugarbaker, Peritoneal Carcinomatosis: Drugs and Diseases, Kluwer Academic, Boston, Mass, USA, 1996.
  24. P. H. Sugarbaker, F. J. Gianola, J. C. Speyer, R. Wesley, I. Barofsky, and C. E. Meyers, “Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer,” Surgery, vol. 98, no. 3, pp. 414–422, 1985. View at Google Scholar · View at Scopus
  25. S. Kusamura, R. Younan, D. Baratti et al., “Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique,” Cancer, vol. 106, no. 5, pp. 1144–1153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Y. Chen, C. Chiles, B. W. Loggie, R. H. Choplin, M. A. Perini, and R. A. Fleming, “Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery,” Journal of Surgical Oncology, vol. 66, no. 1, pp. 19–23, 1997. View at Google Scholar
  27. O. Glehen, D. Osinsky, E. Cotte et al., “Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures,” Annals of Surgical Oncology, vol. 10, no. 8, pp. 863–869, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Witkamp, E. de Bree, M. M. Kaag, G. W. van Slooten, F. van Coevorden, and F. A. N. Zoetmulder, “Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei,” British Journal of Surgery, vol. 88, no. 3, pp. 458–463, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Shen, J. Hawksworth, J. Lovato et al., “Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma,” Annals of Surgical Oncology, vol. 11, no. 2, pp. 178–186, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Montesani, R. de Milito, S. Chiappalone, P. Narilli, A. D'Amato, and G. Ribotta, “Critical evaluation of the anastomoses in large bowel surgery: experience gained in 533 cases,” Hepato-Gastroenterology, vol. 39, no. 4, pp. 304–308, 1992. View at Google Scholar · View at Scopus
  31. H. N. López-Basave, F. Morales-Vasquez, J. M. R. Molina et al., “Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: National Cancer Institute, Mexico City, Mexico,” ISRN Oncology, vol. 2011, Article ID 526384, 6 pages, 2011. View at Publisher · View at Google Scholar
  32. B. W. Loggie, R. A. Fleming, R. P. McQuellon et al., “Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin,” The American Surgeon, vol. 66, no. 6, pp. 561–568, 2000. View at Google Scholar
  33. B. J. Park, H. R. Alexander, S. K. Libutti et al., “Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP),” Annals of Surgical Oncology, vol. 6, no. 6, pp. 582–590, 1999. View at Google Scholar
  34. F. Cavaliere, P. Perri, F. di Filippo et al., “Treatment of peritoneal carcinomatosis with intent to cure,” Journal of Surgical Oncology, vol. 74, no. 1, pp. 41–44, 2000. View at Google Scholar
  35. A. A. Sarnaik, J. J. Sussman, S. A. Ahmad, and A. M. Lowy, “Technology of intraperitoneal chemotherapy administration: a survey of techniques with a review of morbidity and mortality,” Surgical Oncology Clinics of North America, vol. 12, no. 3, pp. 849–863, 2003. View at Google Scholar
  36. T. Fujimura, Y. Yonemura, H. Fujita et al., “Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies,” International Surgery, vol. 84, no. 1, pp. 60–66, 1999. View at Google Scholar
  37. E. A. Levine, J. H. Stewart IV, G. B. Russell, K. R. Geisinger, B. L. Loggie, and P. Shen, “Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy experience with 501 procedures,” Journal of the American College of Surgeons, vol. 204, no. 5, pp. 943–955, 2007. View at Publisher · View at Google Scholar